mesalamine has been researched along with Osteoporosis in 4 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ulcerative colitis is a chronic inflammatory bowel disease." | 2.42 | [Management of ulcerative colitis]. ( Kullak-Ublick, GA; Rammert, Ch, 2003) |
| "There is a high prevalence of low bone mineral density (BMD) among patients with inflammatory bowel disease (IBD) although there is a lack of clinical data on the impact of IBD specific medications and recommended vitamin D (VD) and calcium (Ca) supplements on it." | 1.40 | Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients. ( Cierny, D; Hlavaty, T; Huorka, M; Killinger, Z; Koller, T; Krajcovicova, A; Letkovsky, J; Miznerova, E; Nevidanska, M; Payer, J; Toth, J; Zelinkova, Z, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casanova, MJ | 1 |
| Chaparro, M | 1 |
| Gisbert, JP | 1 |
| Krajcovicova, A | 1 |
| Hlavaty, T | 1 |
| Killinger, Z | 1 |
| Miznerova, E | 1 |
| Toth, J | 1 |
| Letkovsky, J | 1 |
| Nevidanska, M | 1 |
| Cierny, D | 1 |
| Koller, T | 1 |
| Zelinkova, Z | 1 |
| Huorka, M | 1 |
| Payer, J | 1 |
| Rammert, Ch | 1 |
| Kullak-Ublick, GA | 1 |
| Beglinger, Ch | 1 |
2 reviews available for mesalamine and Osteoporosis
| Article | Year |
|---|---|
[Management of ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anemia; Anti-Inflammatory Agent | 2003 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; An | 2003 |
2 other studies available for mesalamine and Osteoporosis
| Article | Year |
|---|---|
Errors in the care of inflammatory bowel disease patients: "Errata" Study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Ambulatory Care; Colonoscopy; Colorectal Ne | 2020 |
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
Topics: Absorptiometry, Photon; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; A | 2014 |